GlucoTrack, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
6.26M
on 2026-06-30, from 4,535 on 2024-03-31 10-Q ↗
Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-09-23. Not read yet. S-3 ↗
$10.0M
Agreement of 2026-07-09. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
0.3 quarters
$1.1M on 2026-06-30 ÷ $4.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-24 | Registered direct offering incl. 1.35M pre-funded | 1,519,608 | not read | $3.1M | 8-K ↗ |
| 2026-09-24 | Registered direct offering incl. 1.35M pre-funded | 1,519,608 | $2.04 | $3.1M | 424B5 ↗ |
| 2026-08-04 | Private placement incl. 2.67M pre-funded | 5,333,334 | not read | $2.0M | 8-K ↗ |
| 2025-12-29 | Private placement incl. 1.03M pre-funded | 2,067,182 | not read | $4.0M | 8-K ↗ |
Also on file: $3.5M convertible notes, 2026-08-04 8-K ↗ · a 1-for-15 reverse split, 2026-08-28 8-K ↗ · $11.6M convertible notes, 2026-09-10 8-K ↗